Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting

v2.4.0.8
Segment Reporting
3 Months Ended
Mar. 31, 2014
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting
The Company evaluates performance based on the operating income (loss) of the respective business segments. The segment results may not represent actual results that would be expected if they were independent, stand-alone businesses. Segment information is as follows (in thousands):
Balance Sheet Data:
As of March 31, 2014
 
Ligand
 
CyDex
 
Total
Total assets
$
40,969

 
$
64,502

 
$
105,471

 
 
 
 
 
 
 
As of December 31, 2013
 
Ligand
 
CyDex
 
Total
Total assets
$
38,408

 
$
66,305

 
$
104,713

 
 
 
 
 
 
Operating Data:
For the three months ended March 31, 2014
 
Ligand
 
CyDex
 
Total
Net revenues from external customers
$
6,791

 
$
9,167

 
$
15,958

Depreciation and amortization expense
66

 
602

 
668

Operating (loss) income
(71
)
 
5,171

 
5,100

Interest expense, net
248

 

 
248

Income tax expense from continuing operations
51

 
2

 
53

 
 
 
 
 
 
 
For the three months ended March 31, 2013
 
Ligand
 
CyDex
 
Total
Net revenues from external customers
$
6,237

 
$
5,414

 
$
11,651

Depreciation and amortization expense
59

 
611

 
670

Operating income
1,396

 
2,536

 
3,932

Interest expense, net
912

 

 
912

Income tax expense from continuing operations
66

 

 
66